IRONWOOD PHARMACEUTICALS, INC.

IRWD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $125.7M $54.0M $261.3M $74.3M $75.5M $136.7M $87.3M $44.3M
Accounts Receivable $3.2M $933.0K $2.9M $10.0K $513.0K $457.0K $74.0K $19.0K
Inventory $735.0K $1.1M $0 $5.0M $22.1M $6.7M
Total Current Assets $311.6M $380.2M $500.2M $288.3M $229.1M $184.4M $167.6M $259.1M
Property, Plant & Equipment $17.3M $20.5M $21.1M $29.8M $37.4M $37.5M $33.6M $34.4M
Goodwill $785.0K $785.0K
Intangible Assets (Excl. Goodwill) $159.9M $166.1M
Total Assets $605.7M $709.8M $619.1M $329.3M $279.0M $229.9M $209.0M $301.4M
Liabilities
Accounts Payable $16.0M $17.7M $8.6M $9.8M $10.1M $14.2M $6.4M $4.3M
Total Current Liabilities $66.0M $91.1M $76.5M $60.5M $41.0M $54.9M $65.1M $64.4M
Long-Term Debt $220.6M
Total Liabilities $595.8M $643.1M $524.0M $240.8M $240.7M $85.9M $99.1M $141.8M
Stockholders' Equity
Retained Earnings $-1.31B $-1.19B $-1.11B $-967.4M $-777.8M $-505.0M $-432.4M $-367.5M
Total Stockholders' Equity $9.8M $66.7M $95.1M $88.6M $38.2M $144.1M $109.9M $159.6M
← Newer Page 2 of 3 Older →